Related Experiment Videos

Treatment for recurrent ovarian cancer. A report of 2 cases

A M Maxwell, J P Jordaan

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde

|February 7, 1987

Abstract:

Two cases of recurrent ovarian adenocarcinoma were resistant to standard combination chemotherapy regimens. Complete response was achieved with salvage therapy comprising cis-platinum 120 mg/m2 intravenously every 3 weeks and VP-16 (etoposide; Bristol-Myers) 200 mg per os weekly.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Electrocardiographic patterns in African University strength and endurance athletes of Zulu descent.

The Journal of sports medicine and physical fitness·2015

A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen.

Cancer chemotherapy and pharmacology·2009

Comparison of an LH-RH analogue (Goeserelin acetate, 'Zoladex') with combined androgen blockade in advanced prostate cancer: final survival results of an international multicentre randomized-trial. International Prostate Cancer Study Group.

European urology·2000

Phase II trial of i.v. vinorelbine and cisplatin in inoperable locally advanced or disseminated non-small-cell lung cancer: the South African experience.

Current medical research and opinion·2000

Fadrozole versus megestrol acetate: a double-blind randomised trial in advanced breast cancer.

Oncology·1998

Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. The Granisetron Study Group.

Annals of oncology : official journal of the European Society for Medical Oncology·1994

See all related articles